Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Revenue

Tango Therapeutics had revenue of $37.23M in the twelve months ending March 31, 2024, with 49.72% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $6.47M with 12.23% year-over-year growth. In the year 2023, Tango Therapeutics had annual revenue of $36.53M with 46.93% growth.

• Revenue (ttm): $37.23M
• Revenue Growth: +49.72%
• P/S Ratio: 21.16
• Revenue / Employee: $265,943
• Employees: 140
• Market Cap: 803.48M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	36.53M	11.67M	46.93%
Dec 31, 2022	24.86M	-12.18M	-32.89%
Dec 31, 2021	37.04M	29.39M	383.83%
Dec 31, 2020	7.66M	-16.99M	-68.94%
Dec 31, 2019	24.65M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.